About Advion
Advion is a Healthcare company based in Ithaca (United States) founded in 1993, and was acquired by Quintiles in February 2012. Microfluidics and mass spectrometry products are provided for clinical research. It operates in the Healthcare and Technology sectors. Advion has raised $45.64 million across 8 funding rounds from investors including Skyline Ventures, Polaris Partners and IQVIA. Advion has completed 1 acquisition, including Interchim. Advion offers products and services including ex press ion CMS, AVANT HPLC, and SOLATION ICP-MS. Its focus areas include Semiconductors, Photonics, Biophotonics and Analytics and Sensing. Its legal entity is ADVION, INC. Its competitors include 908 Devices, BioAgilytix and Impedimed; 2 of its 3 listed competitors have raised funding.
Company details
Advion Biosciences, a spin-off from the Cornell University, is engaged in the development and manufacture of innovative products based on microfluidics and mass spectrometry for life science research and clinical development. The companys proprietary products are expression CMS (Compact Mass Spectrometer), Chip-Mate (a nano-LC ion source), NanoTek(microfluidics flow-chemistry system used for probe synthesis for imaging), Triversa NanoMate(Chip-based electrospray ionization). These products have applications such as reaction monitoring, protein assays, biomarkers and peptide synthesis, PET chemistry, lipid analysis and metabolite identification, radiopharmaceutical research and production. The company has sales and support offices in North America, Europe, and Japan. Advion Bioservices bioanalytical services division was sold off to Quintiles in 2011.
- Headquarters Ithaca, United States
- Stage Acquired
- SectorsHealthcareTechnology
- Email••••••••
- Website advion.com
- Social LinkedIn X YouTube
- Acquired by Quintiles (Feb 2012)
- Legal Name Advion, Inc.
- Total Equity Funding$45.64M (USD)
in 8 rounds
- Latest Funding Round$1.5M (USD), Series D
Jun 2014
- InvestorsSkyline Ventures
& 2 more
- Investments & Acquisitions
- Acquired byQuintiles
(Feb 2012)
Products & Services of Advion
Advion offers a comprehensive portfolio of products and services, including ex press ion CMS, AVANT HPLC, and SOLATION ICP-MS.
Compact mass spectrometer for real-time chemical analysis in labs.
High-performance liquid chromatography system for compound separation.
ICP-MS solution for multi-element detection in scientific testing.
Apps and channels of Advion
its YouTube channel AdvionBioSciences has 128 subscribers and 30 videos.
Videos from Advion
The most watched videos on Advion's YouTube channel, AdvionBioSciences (128 subscribers). Click a video to play it here.
More on AdvionBioSciences.
Funding Insights of Advion
Advion has successfully raised a total of $45.64M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $1.5 million completed in June 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $45.64M
- Total Rounds 8
- Last Round Series D — $1.5M
- First Round $15M
(May 2002)
- Investors Count 2
All 8 funding rounds of Advion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2014 | Debt – Conventional | – | – | – | |
| Jun 2014 | $1.5M | Series D | – | – | – |
| Nov 2013 | $9.18M | Series D | – | – | – |
| Aug 2007 | $9.11M | Series C | – | – | – |
| Oct 2005 | $1.5M | Series B | – | – | – |
| Oct 2004 | $597,910 | Series B | – | – | – |
| Oct 2004 | $8.75M | Series B | – | – | – |
| May 2002 | $15M | Series B | – | – |
3 investors in total: 3 institutional.
Investors in Advion
Advion has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Skyline Ventures, Polaris Partners and IQVIA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US life sciences companies are invested in by Skyline Ventures. | skylineventures.com | Palo Alto, United States | ||
US focused venture capital firm | polarispartners.com | Boston, United States | ||
Healthcare advancements are driven by IQVIA through connected intelligence. | quintiles.com | United States |
Investor details for Advion
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Advion
9 people are tracked at Advion (4 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Vijay Gupta | VP, International Business Development & Support | Leadership |
Jamey Jones | Adchim DG & CEO, Interchim & Advion COO | Leadership |
Wayne Xiong | Chief Financial Officer | Leadership |
Thomas Tran | Deputy General Director, DGA, Adchim, Interchim | Leadership |
Chris Tarshus | Team Leadership | Team |
Pierre - François Icart | Commercial Leadership | Team |
Stéphane Graziani | Team Leadership | Team |
Mark Allen | Commercial Leadership | Team |
Kristy Licari | Commercial Leadership | Team |
Complete people profiles for Advion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Advion
Advion has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Interchim.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Manufacturer of consumables and instruments for research and industry. | interchim.com | Montlucon, France | 1970 | Feb 2020 | •••• |
Complete acquisition details for Advion
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Advion
Competitors of Advion
Advion has 3 listed competitors in our database, 2 of them funded. They include 908 Devices, BioAgilytix and Impedimed.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 908devices.com | 2012 | Boston, United States | $68.22M | 93 | Handheld chemical detection devices are manufactured using mass spectrometry. | |
| bioagilytix.com | 2008 | Durham, United States | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | ||
| impedimed.com | 1999 | Carlsbad, United States | $3.44M | 76 | Technologies for non-invasive fluid status assessment and monitoring are developed. |
Detailed competitors of Advion
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Advion
The website of Advion (advion.com) receives about 8.1K visits a month.
- Monthly visits8.1K
▲ 2.2% vs previous month
Websites whose visitors overlap most with Advion. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| extrel.com | 100% | View details | |||
teledynelabs.com | teledynelabs.com | 96% | #1,150,621 | – | |
| aob.com | 86% | 15.1K | #1,915,330 | View details | |
| kore.co.uk | 86% | 1.7K | #11,439,196 | View details | |
ion-tof.com | ion-tof.com | 86% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for Advion
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Advion (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Advion
Complete news archive for Advion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Advion
Advion was founded in 1993 and raised its 1st funding round 9 years after it was founded.
Advion is headquartered in Ithaca, United States. It is registered at Ithaca, New York, United States.
Advion is a funded company, having raised a total of $45.64M across 8 funding rounds to date. The company's 1st funding round was a Series B of $15M, raised on May 2002.
Advion Biosciences, a spin-off from the Cornell University, is engaged in the development and manufacture of innovative products based on microfluidics and mass spectrometry for life science research and clinical development. The companys proprietary products are expression CMS (Compact Mass Spectrometer), Chip-Mate (a nano-LC ion source), NanoTek(microfluidics flow-chemistry system used for probe synthesis for imaging), Triversa NanoMate(Chip-based electrospray ionization). These products have applications such as reaction monitoring, protein assays, biomarkers and peptide synthesis, PET chemistry, lipid analysis and metabolite identification, radiopharmaceutical research and production. The company has sales and support offices in North America, Europe, and Japan. Advion Bioservices bioanalytical services division was sold off to Quintiles in 2011.
Advion's top competitors include 908 Devices, BioAgilytix and Impedimed.
Advion offers ex press ion CMS, AVANT HPLC, and SOLATION ICP-MS.
Advion has made 1 acquisition, including Interchim.
Advion has 3 investors. Key investors include Skyline Ventures, Polaris Partners, and IQVIA.
Advion operates through Advion, Inc..
Yes. Advion was acquired by Quintiles in February 2012.